Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Living with severe asthma year 2016

Paraskevi Katsaounou, Lorena Garcia Conde, Claus Kroegel, Robin Gore, Francesco Menzella, Cristian Domingo Ribas, Mario Morais Almeida, Michael E Hyland, Matthias Gasser, Ismail Kasujee, Mikaela Odemyr
European Respiratory Journal 2017 50: PA4682; DOI: 10.1183/1393003.congress-2017.PA4682
Paraskevi Katsaounou
1Medical School National and Kapodistrian, University of athens, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorena Garcia Conde
2Novartis Pharma AG, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claus Kroegel
3Department of Pneumology & Allergy / Immunology, Medical University Clinic Jena, Jena, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robin Gore
4Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Menzella
5Specialist Medicine Department, Pneumology Unit, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristian Domingo Ribas
6Corporació Sanitària Parc Taulí, barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario Morais Almeida
7ACUF Lisbon Allergy Center, Lisbon, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael E Hyland
8Plymouth University, Plymouth, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Gasser
9GfK Switerland, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ismail Kasujee
2Novartis Pharma AG, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikaela Odemyr
10The European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

Objective: To assess the impact of severe asthma on daily life (asthma control, activity, psychological aspects, treatment).

Methods: Data were collected from 1333 adults and children (through caregivers) with severe persistent asthma in 9 countries through an online survey done by GfK on behalf of Novartis in 2016 (Table 1a).

Results: Severe asthmatics were diagnosed by respiratory physicians (42%), general practitioners (30%), allergists (21%) and paediatricians (6%). On average, adults were diagnosed 15 years ago, adolescents 7 years and pediatrics 3 years ago. As per patients’ knowledge, 47% were non-allergic. A large discrepancy was seen between real-life control according to GINA guidelines (6%) and self-estimated control (42%). In the previous year, 73% of patients experienced exacerbations that required treatment from a healthcare professional (emergency room, ambulance, physician at home); 34% had ≥2 exacerbations (13%, three; 7%, four; 3%, five; 11%, more than 5). On an average, 20 days of OCS use was reported in the last 6 months. The impact on psychology and activities is shown in Table 1b.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Conclusions: Although asthma control is GINA’s main goal, severe asthmatics are uncontrolled with poor quality of life as reflected in their psychological profile and everyday activities. There is a strong disconnect between perceived and actual asthma control. More action is needed to help severe asthmatics achieve control and live normal unrestricted lives.

  • Copyright ©the authors 2017
Previous
Back to top
Vol 50 Issue suppl 61 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Living with severe asthma year 2016
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Living with severe asthma year 2016
Paraskevi Katsaounou, Lorena Garcia Conde, Claus Kroegel, Robin Gore, Francesco Menzella, Cristian Domingo Ribas, Mario Morais Almeida, Michael E Hyland, Matthias Gasser, Ismail Kasujee, Mikaela Odemyr
European Respiratory Journal Sep 2017, 50 (suppl 61) PA4682; DOI: 10.1183/1393003.congress-2017.PA4682

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Living with severe asthma year 2016
Paraskevi Katsaounou, Lorena Garcia Conde, Claus Kroegel, Robin Gore, Francesco Menzella, Cristian Domingo Ribas, Mario Morais Almeida, Michael E Hyland, Matthias Gasser, Ismail Kasujee, Mikaela Odemyr
European Respiratory Journal Sep 2017, 50 (suppl 61) PA4682; DOI: 10.1183/1393003.congress-2017.PA4682
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Late Breaking Abstract - Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease - COPD-ST2OP: a phase IIa, placebo-controlled trial
  • Omalizumab exposure patterns in real-life: An 11-year French population-based study of 19,203 patients with severe asthma
  • Long-term oral corticosteroid-sparing effects of anti-IL5/anti-IL5 receptor treatment
Show more Airway pharmacology and treatment

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society